STOCK TITAN

Bolt Biotherapeutics (BOLT) Revenue by Year

BOLT NASDAQ

Bolt Biotherapeutics, Inc. generated $7.7M in revenue in fiscal year 2025. This represents an increase of 0.1% from the prior fiscal year. Over the trailing 12 months, Q4 FY2025 through Q3 FY2026, the same line adds up to $2.5M in revenue. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Bolt Biotherapeutics, Inc. has filed alongside them.

FY2025 annual
Revenue $7.7M
YoY +0.1%
5Y CAGR +101.6%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

BOLT Revenue by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-K
Revenue$2.5M$7.7M+0.1%$7.7M-2.4%$7.9M+37.5%$5.7M+354.7%$1.3M+445.5%$231K

TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.

BOLT Revenue by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Revenue$0-100.0%$5K-99.7%$26K-97.9%$2.5Mn/m$2.2M+90.1%$1.8M+41.5%$1.2M-76.8%$0-100.0%$1.1M-54.9%$1.3M-11.0%$5.3M+188.8%$2.1M+48.1%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Bolt Biotherapeutics, Inc. financials

Frequently Asked Questions

Bolt Biotherapeutics, Inc. generated $7.7M in revenue in fiscal year 2025.

Bolt Biotherapeutics, Inc. (BOLT) revenue rose by 0.1% year over year, from $7.7M to $7.7M in fiscal year 2025.

Bolt Biotherapeutics, Inc. (BOLT) reported $2.5M in revenue over the trailing 12 months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.

Across the 6 fiscal years this page covers, Bolt Biotherapeutics, Inc. (BOLT) revenue went from $231K in fiscal year 2020 to $7.7M in fiscal year 2025.

Bolt Biotherapeutics, Inc. (BOLT) reported $0 in revenue in Q3 2026. This represents a decrease of 100.0% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Bolt Biotherapeutics, Inc. (BOLT) reported on that line in every period on record.